Scientists say research into mental illnesses such as depression is facing a funding crisis.
They warn that new treatments will be delayed and that the next generation of neuroscience researchers will not be trained.
A report by the European College of Neuropsychopharmacology said private companies were pulling out due to the challenge of bringing drugs to market.
It called for more investment and changes to the way trials take place.
Read more at: